Autoimmune Lymphoproliferative Syndrome, Type IA: Clinical Trials

4 trials for Autoimmune Lymphoproliferative Syndrome, Type IA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1
Phase 41Completed 1

Follow Autoimmune Lymphoproliferative Syndrome, Type IA: new trials by email Literature Review of Autoimmune Lymphoproliferative Syndrome, Type IA trials Research Report on Autoimmune Lymphoproliferative Syndrome, Type IA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
Soquelitinib - Autoimmune Lymphoproliferative Syndrome
Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)152025-03-102026-09-08
Phase I, KM-819 in Healthy Subjects for Parkinson's Disease
KM-819, Placebo - Parkinson's Disease
Phase 1CompletedKainos Medicine Inc.882016-11-012020-04-13
Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
ramipril - Proteinuria, Diabetic Nephropathy
Phase 4CompletedGulhane School of Medicine782008-01-012009-06-03
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Benign Lymphoproliferative Disorder
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)12001993-05-132026-10-08

Narrower conditions

Autoimmune Diseases (1)  ·  Autoimmune Lymphoproliferative Syndrome (1)  ·  Diabetic Nephropathies (1)  ·  Hypersplenism (1)  ·  Parkinson Disease (1)  ·  Proteinuria (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Immune System Diseases (2)  ·  Autoimmune Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

KM-819 (1)  ·  Ramipril (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Gulhane School of Medicine (1)  ·  Kainos Medicine Inc. (1)

Countries

United States (2)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

V. Koneti Rao, M.D. (2)  ·  Jae Moon Lee, PhD (1)  ·  Mahmut I Yilmaz, MD (1)

Results publications

PMID 21885601, PMID 25359994, PMID 27846610